![Gary Phillips](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gary Phillips
Vorstandsvorsitzender bei
SYNTARA LIMITED
Vermögen: 40 296 $ am 31.05.2026
Profil
Gary Jonathan Phillips is Chief Executive Officer, Executive Director & MD at Syntara Ltd. since 2013 and a Member of the Australian Institute of Co. Directors.
Former roles include Chief Executive Officer-Hungary at Ciba-Geigy AG from 1992 to 1998, Chief Executive Officer-Pharmaceutical Division at Novartis Australia Pty Ltd., Area Director-Asia at Novartis AG, and Independent Non-Executive Director at Arovella Therapeutics Ltd. from 2022 to 2026.
Education includes an MBA from Henley Business School Ltd. and an undergraduate degree from The University of Nottingham.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 09.02.2026 | 788’888 ( 0.07% ) | 40 296 $ | 31.05.2026 |
Aktive Positionen von Gary Phillips
| Unternehmen | Position | Beginn |
|---|---|---|
| SYNTARA LIMITED | Vorstandsvorsitzender | 12.03.2013 |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Gary Phillips
| Unternehmen | Position | Ende |
|---|---|---|
| AROVELLA THERAPEUTICS LIMITED | Direktor/Vorstandsmitglied | 09.02.2026 |
Ciba-Geigy AG
 Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | 01.01.1998 |
| NOVARTIS AG | Corporate Officer/Principal | 31.12.1996 |
Novartis Australia Pty Ltd.
 Novartis Australia Pty Ltd. BiotechnologyHealth Technology Manufactures biological products | Corporate Officer/Principal | - |
Ausbildung von Gary Phillips
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
85
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Syntara Ltd.
 Syntara Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and wholesales pharmaceutical products for respiratory disorders | Health Technology |
Henley Business School Ltd.
 Henley Business School Ltd. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Ciba-Geigy AG
Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Arovella Therapeutics Ltd.
 Arovella Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and distributes medical devices and consumables | Health Technology |
The University of Nottingham
 The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
Novartis Australia Pty Ltd.
Novartis Australia Pty Ltd. BiotechnologyHealth Technology Manufactures biological products | Health Technology |
